Patents Assigned to NEOSTEM ONCOLOGY, LLC
  • Antigen presenting cancer vaccine
    Patent number: 9555058
    Abstract: The disclosure provides reagents, methods, and kits, for treating melanoma. The reagent encompasses interferon-gamma (IFN-gamma) responsive melanoma cells, where the cells are autophagic and non-apoptotic melanoma cells, and where the cells express MHC Class II. In another aspect, the reagent encompassed dendritic cells loaded with the IFN-gamma responsive, non-apoptotic, MHC Class II-expressing melanoma cells.
    Type: Grant
    Filed: October 22, 2012
    Date of Patent: January 31, 2017
    Assignee: Neostem Oncology, LLC
    Inventors: Andrew Cornforth, Robert Dillman
  • HIGH PURITY OVARIAN CANCER STEM CELLS FOR ACTIVE AUTOLOGOUS IMMUNE THERAPY
    Publication number: 20160058855
    Abstract: The disclosure provides cancer stem cells, for use in stimulating immune response against a cancer, such as ovarian carcinoma. Methods for preparing and purifying the cancer stem cells are provided.
    Type: Application
    Filed: March 10, 2014
    Publication date: March 3, 2016
    Applicant: NEOSTEM ONCOLOGY, LLC
    Inventors: Andrew N. CORNFORTH, Gabriel NISTOR
  • Individualized High Purity Glioblastoma Multiforme Stem Cells and Methods for Stimulating Immune Response
    Publication number: 20160030537
    Abstract: The present disclosure provides reagents and methods for stimulating an immune response against an antigen associated with glioblastoma multiforme.
    Type: Application
    Filed: March 12, 2014
    Publication date: February 4, 2016
    Applicant: NEOSTEM ONCOLOGY, LLC
    Inventors: Candace Y. Hsieh, Andrew N. Cornforth, Gabriel Nistor
  • INDIVIDUALIZED HIGH PURITY COLON CARCINOMA STEM CELLS, METHODS AND USE OF THE SAME
    Publication number: 20160022789
    Abstract: The disclosure provides cancer stem cells, for use in stimulating immune response against a cancer, such as colon carcinoma (CC). Methods for preparing and purifying the cancer stem cells are provided.
    Type: Application
    Filed: March 12, 2014
    Publication date: January 28, 2016
    Applicant: NEOSTEM ONCOLOGY, LLC
    Inventors: Candace Y. Hsieh, Andrew N. Cornforth, Gabriel Nistor
  • INDIVIDUALIZED HIGH PURITY HEPATOCELLULAR CARCINOMA STEM CELLS, METHODS AND USE OF THE SAME
    Publication number: 20160017293
    Abstract: The disclosure provides cancer stem cells, for use in stimulating immune response against a cancer, such as hepatocellular carcinoma (HCC). Methods for preparing and purifying the cancer stem cells are provided.
    Type: Application
    Filed: March 6, 2014
    Publication date: January 21, 2016
    Applicant: NEOSTEM ONCOLOGY, LLC
    Inventors: Gabriel Nistor, Craig T. Frederickson, Andrew N. Cornforth